Literature DB >> 28173947

Cost analysis of nonoperative management of acute appendicitis in children.

Martina Mudri1, Kamary Coriolano2, Andreana Bütter3.   

Abstract

PURPOSE: The purpose of this study was to determine if nonoperative management of acute appendicitis in children is more cost effective than appendectomy.
METHODS: A retrospective review of children (6-17years) with acute appendicitis treated nonoperatively (NOM) from May 2012 to May 2015 was compared to similar patients treated with laparoscopic appendectomy (OM) (IRB#107535). Inclusion criteria included symptoms ≤48h, localized peritonitis, and ultrasound confirmation of acute appendicitis. Variables analyzed included failure rates, complications, length of stay (LOS), and cost analysis.
RESULTS: 26 NOM patients (30% female, mean age 12) and 26 OM patients (73% female, mean age 11) had similar median initial LOS (24.5h (NOM) vs 16.5h (OM), p=0.076). Median total LOS was significantly longer in the NOM group (34.5h (NOM) vs 17.5 (OM), p=0.01). Median cost of appendectomy was $1416.14 (range $781.24-$2729.97). 9/26 (35%) NOM patients underwent appendectomy for recurrent appendicitis. 4/26 (15%) OM patients were readmitted (postoperative abscess (n=2), Clostridium difficile colitis (n=1), postoperative nausea/vomiting (n=1)). Median initial hospital admission costs were significantly higher in the OM group ($3502.70 (OM) vs $1870.37 (NOM), p=0.004)). However, median total hospital costs were similar for both groups ($3708.68 (OM) vs $2698.99 (NOM), p=0.065)).
CONCLUSION: Although initial costs were significantly less in children with acute appendicitis managed nonoperatively, total costs were similar for both groups. The high failure rate of nonoperative management in this series contributed to the total increased cost in the NOM group. LEVEL OF EVIDENCE: 3b.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Appendicitis; Cost analysis; Nonoperative management; Pediatric

Mesh:

Substances:

Year:  2017        PMID: 28173947     DOI: 10.1016/j.jpedsurg.2017.01.050

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  Conservative antibiotic treatment for acute uncomplicated appendicitis is feasible.

Authors:  Zvi Steiner; Genady Buklan; Michael Gutermacher; Ita Litmanovitz; Tal Landa; Shmuel Arnon
Journal:  Pediatr Surg Int       Date:  2018-01-17       Impact factor: 1.827

2.  New Criteria Could Improve the Success Rate of Non-operative Management of Acute Appendicitis in Children.

Authors:  Osman Uzunlu; Incinur Genisol
Journal:  Cureus       Date:  2022-06-11

3.  Delayed Operative Management in Complicated Acute Appendicitis-Is Avoiding Extended Resection Worth the Wait ? Results from a Global Cohort Study.

Authors:  Rodrigo Moisés de Almeida Leite; Alexandre Venancio de Souza; Camdem Phillip Bay; Christy Cauley; Liliana Bordeianou; Rob Goldstone; Todd Francone; Hiroko Kunitake; Rocco Ricciardi
Journal:  J Gastrointest Surg       Date:  2022-04-21       Impact factor: 3.267

4.  Conservative treatment for uncomplicated appendicitis in children: the CONTRACT feasibility study, including feasibility RCT.

Authors:  Nigel J Hall; Frances C Sherratt; Simon Eaton; Isabel Reading; Erin Walker; Maria Chorozoglou; Lucy Beasant; Wendy Wood; Michael Stanton; Harriet J Corbett; Dean Rex; Natalie Hutchings; Elizabeth Dixon; Simon Grist; William Van't Hoff; Esther Crawley; Jane Blazeby; Bridget Young
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

5.  Disease burden of appendectomy for appendicitis: a population-based cohort study.

Authors:  Elisabeth M L de Wijkerslooth; Anne Loes van den Boom; Bas P L Wijnhoven
Journal:  Surg Endosc       Date:  2019-03-27       Impact factor: 4.584

Review 6.  Nonoperative treatment for nonperforated appendicitis in children: a systematic review and meta-analysis.

Authors:  Sonia Maita; Björn Andersson; Jan F Svensson; Tomas Wester
Journal:  Pediatr Surg Int       Date:  2019-12-14       Impact factor: 1.827

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.